Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Cite this paper

@article{Sgroi2013PredictionOL, title={Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.}, author={Dennis C. Sgroi and Ivana Sestak and Jack Cuzick and Yi Zhang and Catherine A. Schnabel and Brock E. Schroeder and Mark G. Erlander and Anita K. Dunbier and Kally Sidhu and Elena L{\'o}pez-Knowles and Paul E Goss and Mitch Dowsett}, journal={The Lancet. Oncology}, year={2013}, volume={14 11}, pages={1067-76} }